188 related articles for article (PubMed ID: 32492138)
1. No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.
de Ligt M; Bergman M; Fuentes RM; Essers H; Moonen-Kornips E; Havekes B; Schrauwen-Hinderling VB; Schrauwen P
Am J Clin Nutr; 2020 Oct; 112(4):1029-1038. PubMed ID: 32492138
[TBL] [Abstract][Full Text] [Related]
2. Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance.
Zhang X; Xiao D; Guzman G; Edirisinghe I; Burton-Freeman B
J Nutr; 2022 Aug; 152(8):1851-1861. PubMed ID: 35700149
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D supplementation has no effect on insulin sensitivity or secretion in vitamin D-deficient, overweight or obese adults: a randomized placebo-controlled trial.
Mousa A; Naderpoor N; de Courten MP; Teede H; Kellow N; Walker K; Scragg R; de Courten B
Am J Clin Nutr; 2017 Jun; 105(6):1372-1381. PubMed ID: 28490514
[No Abstract] [Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial.
Kantartzis K; Fritsche L; Bombrich M; Machann J; Schick F; Staiger H; Kunz I; Schoop R; Lehn-Stefan A; Heni M; Peter A; Fritsche A; Häring HU; Stefan N
Diabetes Obes Metab; 2018 Jul; 20(7):1793-1797. PubMed ID: 29484808
[TBL] [Abstract][Full Text] [Related]
6. Effect of 12 wk of resistant starch supplementation on cardiometabolic risk factors in adults with prediabetes: a randomized controlled trial.
Peterson CM; Beyl RA; Marlatt KL; Martin CK; Aryana KJ; Marco ML; Martin RJ; Keenan MJ; Ravussin E
Am J Clin Nutr; 2018 Sep; 108(3):492-501. PubMed ID: 30010698
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women: A 24-month randomised, double-blind, placebo-controlled, crossover study.
Thaung Zaw JJ; Howe PR; Wong RH
Clin Nutr; 2021 Mar; 40(3):820-829. PubMed ID: 32900519
[TBL] [Abstract][Full Text] [Related]
8. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.
Poulsen MM; Vestergaard PF; Clasen BF; Radko Y; Christensen LP; Stødkilde-Jørgensen H; Møller N; Jessen N; Pedersen SB; Jørgensen JO
Diabetes; 2013 Apr; 62(4):1186-95. PubMed ID: 23193181
[TBL] [Abstract][Full Text] [Related]
9. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects.
Dollerup OL; Christensen B; Svart M; Schmidt MS; Sulek K; Ringgaard S; Stødkilde-Jørgensen H; Møller N; Brenner C; Treebak JT; Jessen N
Am J Clin Nutr; 2018 Aug; 108(2):343-353. PubMed ID: 29992272
[TBL] [Abstract][Full Text] [Related]
10. Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.
Wicklow B; Wittmeier K; T' Jong GW; McGavock J; Robert M; Duhamel T; Dolinsky VW
Biochem Cell Biol; 2015 Oct; 93(5):522-30. PubMed ID: 26305052
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial.
van der Made SM; Plat J; Mensink RP
PLoS One; 2015; 10(3):e0118393. PubMed ID: 25790328
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
Remie CME; Roumans KHM; Moonen MPB; Connell NJ; Havekes B; Mevenkamp J; Lindeboom L; de Wit VHW; van de Weijer T; Aarts SABM; Lutgens E; Schomakers BV; Elfrink HL; Zapata-Pérez R; Houtkooper RH; Auwerx J; Hoeks J; Schrauwen-Hinderling VB; Phielix E; Schrauwen P
Am J Clin Nutr; 2020 Aug; 112(2):413-426. PubMed ID: 32320006
[TBL] [Abstract][Full Text] [Related]
13. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
Libman IM; Miller KM; DiMeglio LA; Bethin KE; Katz ML; Shah A; Simmons JH; Haller MJ; Raman S; Tamborlane WV; Coffey JK; Saenz AM; Beck RW; Nadeau KJ;
JAMA; 2015 Dec; 314(21):2241-50. PubMed ID: 26624824
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.
Nwosu BU; Maranda L; Cullen K; Greenman L; Fleshman J; McShea N; Barton BA; Lee MM
PLoS One; 2015; 10(9):e0137525. PubMed ID: 26367281
[TBL] [Abstract][Full Text] [Related]
15. Novel Multi-Ingredient Supplement Facilitates Weight Loss and Improves Body Composition in Overweight and Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Nederveen JP; Mastrolonardo AJ; Xhuti D; Di Carlo A; Manta K; Fuda MR; Tarnopolsky MA
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686725
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial.
Safarpour P; Daneshi-Maskooni M; Vafa M; Nourbakhsh M; Janani L; Maddah M; Amiri FS; Mohammadi F; Sadeghi H
BMC Fam Pract; 2020 Feb; 21(1):26. PubMed ID: 32033527
[TBL] [Abstract][Full Text] [Related]
17. Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects.
Most J; Goossens GH; Jocken JW; Blaak EE
Int J Obes (Lond); 2014 May; 38(5):698-706. PubMed ID: 24317366
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
19. Effect of a Low-Fat Vegan Diet on Body Weight, Insulin Sensitivity, Postprandial Metabolism, and Intramyocellular and Hepatocellular Lipid Levels in Overweight Adults: A Randomized Clinical Trial.
Kahleova H; Petersen KF; Shulman GI; Alwarith J; Rembert E; Tura A; Hill M; Holubkov R; Barnard ND
JAMA Netw Open; 2020 Nov; 3(11):e2025454. PubMed ID: 33252690
[TBL] [Abstract][Full Text] [Related]
20. Reversal of Insulin Resistance in Overweight and Obese Subjects by
Rabbani N; Xue M; Weickert MO; Thornalley PJ
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
